Patients with late-stage lung and skin cancer may have just won an unlikely ally: the COVID-19 mRNA vaccine. Researchers at ...

An international team led by Monash University researchers has uncovered the genetic code governing the way genetic mutations ...

By casting doubt about the promise of mRNA tech, RFK Jr. is slowing progress toward highly effective therapies that could ...

The breakthrough mRNA vaccine that enabled the world to fight Covid-19 may also be used to fight cancers of the lung or skin, ...

A team led by Neil King, a biochemistry professor at the University of Washington School of Medicine, is now exploring a new ...

Lung cancer and melanoma patients immunized with this formula doubled their chances of surviving three years, according to a ...

A multi-institutional team led by University of Washington scientists have engineered a new vaccine platform combining mRNA ...

Interferon lambda concentrations in nasal lining fluid fell in or above the predicted therapeutic range with a nasally ...

An mRNA cancer vaccine carries its own immune booster and lights up when it starts working, showing treatment success in mice ...

Moderna Inc. (NASDAQ:MRNA) is one of the best high volume stocks to buy according to Wall Street analysts. On October 13, ...

Patients with advanced lung or skin cancer who received a COVID-19 mRNA vaccine within 100 days of starting immunotherapy ...

The mRNA therapeutics market offers key opportunities in developing vaccines and treatments for chronic and infectious diseases, driven by successful clinical trials and increased government and ...